Cellectar Biosciences (NASDAQ: CLRB) reported Q1 EPS of $0.11, $0.30 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $89.3 million.

For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.